Treatment of reactive and distrofisesky diseases of sialadens at people of advanced and senile age

Lobeyko, V. V. and Ryzhak, G. A. and Dyakonov, M. M. and Iordanishvili, A. K. (2015) Treatment of reactive and distrofisesky diseases of sialadens at people of advanced and senile age. Kuban Scientific Medical Bulletin, 1. pp. 69-74.

[thumbnail of 270-269-1-PB.pdf] Text
270-269-1-PB.pdf - Published Version

Download (446kB)

Abstract

It is carried out the retrospective analysis and an assessment of efficiency of treatment of 13 patients (1 men and 12 women) aged from 49 till 79 years which were on hospitalization concerning sialoses. From Mikulich's illness 5 women aged from 46 till 59 years suffered. Concerning Shegren's syndrome treatment there passed 8 people (1 man and 7 women) aged from 59 till 77 years. On the basis of kompleknsy treatment of 16 patients of advanced and senile age (1 man and 15 women) aged from 61 till 77 years suffering from sialoses, including Mikulich's illness of 5 women aged from 61 till 72 years and Shegren's syndrome of 11 people (1 man and 10 women) aged from 63 till 77 years, ways of an assessment of severity of the specified pathology and efficiency of its treatment at adults of different age groups are offered. Sovershenstvovana a technique of treatment of sialoses at people of the senior age groups with application of bioproofreaders of a delivery of «lesmin», «yodemam», «fitolon», linimentum of a tsikloferon, the peptide vezugen bioregulator. Importance of regular carrying out antirecurrent treatment-and-prophylactic actions in the course of dynamic observation over patients of advanced and senile age, a stradayushchimisialozama that leads to improvement of quality of their life is shown.

Item Type: Article
Subjects: Digital Open Archives > Medical Science
Depositing User: Unnamed user with email support@digiopenarchives.com
Date Deposited: 05 Apr 2023 06:07
Last Modified: 22 Oct 2024 04:17
URI: http://geographical.openuniversityarchive.com/id/eprint/811

Actions (login required)

View Item
View Item